| First Author | Moog MT | Year | 2022 |
| Journal | J Immunol | Volume | 208 |
| Issue | 5 | Pages | 1259-1271 |
| PubMed ID | 35149532 | Mgi Jnum | J:336697 |
| Mgi Id | MGI:7257966 | Doi | 10.4049/jimmunol.2100767 |
| Citation | Moog MT, et al. (2022) B Cells Are Not Involved in the Regulation of Adenoviral TGF-beta1- or Bleomycin-Induced Lung Fibrosis in Mice. J Immunol 208(5):1259-1271 |
| abstractText | Idiopathic pulmonary fibrosis (IPF) is an irreversible, age-related diffuse parenchymal lung disease of poorly defined etiology. Many patients with IPF demonstrate distinctive lymphocytic interstitial infiltrations within remodeled lung tissue with uncertain pathogenetic relevance. Histopathological examination of explant lung tissue of patients with IPF revealed accentuated lymphoplasmacellular accumulations in close vicinity to, or even infiltrating, remodeled lung tissue. Similarly, we found significant accumulations of B cells interfused with T cells within remodeled lung tissue in two murine models of adenoviral TGF-beta1 or bleomycin (BLM)-induced lung fibrosis. Such B cell accumulations coincided with significantly increased lung collagen deposition, lung histopathology, and worsened lung function in wild-type (WT) mice. Surprisingly, B cell-deficient microMT knockout mice exhibited similar lung tissue remodeling and worsened lung function upon either AdTGF-beta1 or BLM as for WT mice. Comparative transcriptomic profiling of sorted B cells collected from lungs of AdTGF-beta1- and BLM-exposed WT mice identified a large set of commonly regulated genes, but with significant enrichment observed for Gene Ontology terms apparently not related to lung fibrogenesis. Collectively, although we observed B cell accumulations in lungs of IPF patients as well as two experimental models of lung fibrosis, comparative profiling of characteristic features of lung fibrosis between WT and B cell-deficient mice did not support a major involvement of B cells in lung fibrogenesis in mice. |
